Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics-Reference-Cited by-同舟云学术

Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics

Published:2010-04-07 Issue:1 Volume:124 Page:251-258
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Zuradelli Monica,Peissel Bernard,Manoukian Siranoush,Zaffaroni Daniela,Barile Monica,Pensotti Valeria,Cavallari Ugo,Masci Giovanna,Mariette Frederique,Benski Anne Caroline,Santoro Armando,Radice Paolo

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-010-0853-8.pdf

Reference27 articles.

1. Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA (1999) The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet 64:963–970

2. Struewing J, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC (1995) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11:198–200

3. Roa B, Boyd A, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185–187

4. Oddoux C, Struewing J, Clayton C, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K (1996) The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 14:188–190

5. Randall TC, Bell KA, Rebane BA, Rubin SC, Boyd J (1998) Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient. Gynecol Oncol 70:432–434

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients;Cancers;2024-07-15

2. Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants;Breast Cancer Research and Treatment;2024-06-20

3. Metastatic breast cancer with double heterozygosity for the BRCA1 and BRCA2 genes responding to olaparib: A case report;Oncology Letters;2024-04-09

4. How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?;BMC Medical Genomics;2022-05-31

5. The genetics of hereditary cancer risk syndromes in Brazil: a comprehensive analysis of 1682 patients;European Journal of Human Genetics;2022-05-09